electroCore to Participate in the JMP Securities MedTech Bio Summit
electroCore, a bioelectronic medicine company, will have CEO Dan Goldberger participate in a fireside chat at the JMP Securities MedTech Bio Summit on October 1, 2020, at 2:00 PM ET. This virtual event will be accessible via a live webcast, furthering the company's outreach and engagement with investors.
electroCore focuses on non-invasive vagus nerve stimulation therapies, currently targeting migraine and cluster headache treatments. For more details, visit www.electrocore.com.
- None.
- None.
BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held virtually October 1-2, 2020.
Event details:
Date: Thursday, October 1, 2020
Time: 2:00pm ET
Audio from the event will be webcast live and available here or on the Investors section of the company’s website.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com
or
Media Contact:
Jackie Dorsky
electroCore
973-290-0097
FAQ
When will Dan Goldberger speak at the JMP Securities MedTech Bio Summit?
How can I listen to the electroCore webcast?
What therapies does electroCore focus on?